What is the purpose of ultra-processed food? An exploratory analysis of the financialisation of ultra-processed food corporations and implications for public health.

Commercial determinants of health Corporate governance Dietary transition Financialization Ultra-processed foods

Journal

Globalization and health
ISSN: 1744-8603
Titre abrégé: Global Health
Pays: England
ID NLM: 101245734

Informations de publication

Date de publication:
13 Nov 2023
Historique:
received: 19 09 2023
accepted: 08 11 2023
medline: 15 11 2023
pubmed: 14 11 2023
entrez: 14 11 2023
Statut: epublish

Résumé

In recent decades there has been a global rise in consumption of ultra-processed foods (UPFs) to the detriment of population health and the environment. Large corporations that have focused heavily on low-cost manufacturing and extensive marketing of UPFs to maximise profits have driven this dietary transition. The same corporations claim to serve the interests of multiple 'stakeholders', and that they are contributing to sustainable development. This paper aimed to test these claims by examining the degree to which UPF corporations have become 'financialised', focusing on the extent to which they have prioritised the financial interests of their shareholders relative to other actors, as well as the role that various types of investors have played in influencing their governance. Findings were used to inform discussion on policy responses to improve the healthiness of population diets. We adopted an exploratory research design using multiple methods. We conducted quantitative analysis of the financial data of U.S. listed food and agricultural corporations between 1962 and 2021, share ownership data of a selection of UPF corporations, and proxy voting data of a selection of investors between 2012 and 2022. We also conducted targeted narrative reviews using structured and branching searches of academic and grey literature. Since the 1980s, corporations that depend heavily on manufacturing and marketing UPFs to generate profits have been increasingly transferring money to their shareholders relative to their total revenue, and at a level considerably higher than other food and agricultural sectors. In recent years, large hedge fund managers have had a substantial influence on the governance of major UPF corporations in their pursuit of maximising short-term returns. In comparison, shareholders seeking to take steps to improve population diets have had limited influence, in part because large asset managers mostly oppose public health-related shareholder proposals. The operationalisation of 'shareholder primacy' by major UPF corporations has driven inequity and undermines their claims that they are creating 'value' for diverse actors. Measures that protect population diets and food systems from the extractive forces of financialisation are likely needed as part of efforts to improve the healthiness of population diets.

Sections du résumé

BACKGROUND BACKGROUND
In recent decades there has been a global rise in consumption of ultra-processed foods (UPFs) to the detriment of population health and the environment. Large corporations that have focused heavily on low-cost manufacturing and extensive marketing of UPFs to maximise profits have driven this dietary transition. The same corporations claim to serve the interests of multiple 'stakeholders', and that they are contributing to sustainable development. This paper aimed to test these claims by examining the degree to which UPF corporations have become 'financialised', focusing on the extent to which they have prioritised the financial interests of their shareholders relative to other actors, as well as the role that various types of investors have played in influencing their governance. Findings were used to inform discussion on policy responses to improve the healthiness of population diets.
METHODS METHODS
We adopted an exploratory research design using multiple methods. We conducted quantitative analysis of the financial data of U.S. listed food and agricultural corporations between 1962 and 2021, share ownership data of a selection of UPF corporations, and proxy voting data of a selection of investors between 2012 and 2022. We also conducted targeted narrative reviews using structured and branching searches of academic and grey literature.
RESULTS RESULTS
Since the 1980s, corporations that depend heavily on manufacturing and marketing UPFs to generate profits have been increasingly transferring money to their shareholders relative to their total revenue, and at a level considerably higher than other food and agricultural sectors. In recent years, large hedge fund managers have had a substantial influence on the governance of major UPF corporations in their pursuit of maximising short-term returns. In comparison, shareholders seeking to take steps to improve population diets have had limited influence, in part because large asset managers mostly oppose public health-related shareholder proposals.
CONCLUSIONS CONCLUSIONS
The operationalisation of 'shareholder primacy' by major UPF corporations has driven inequity and undermines their claims that they are creating 'value' for diverse actors. Measures that protect population diets and food systems from the extractive forces of financialisation are likely needed as part of efforts to improve the healthiness of population diets.

Identifiants

pubmed: 37957671
doi: 10.1186/s12992-023-00990-1
pii: 10.1186/s12992-023-00990-1
pmc: PMC10644600
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

85

Subventions

Organisme : Bloomberg Philanthropies
ID : Bloomberg Philanthropies

Informations de copyright

© 2023. The Author(s).

Références

Nutrients. 2020 Jun 30;12(7):
pubmed: 32630022
Rev Saude Publica. 2022 Feb 28;56:6
pubmed: 35239844
Br J Nutr. 2021 Feb 14;125(3):308-318
pubmed: 32792031
Curr Obes Rep. 2014 Jun;3(2):256-72
pubmed: 26626606
Neurology. 2022 Sep 6;99(10):e1056-e1066
pubmed: 36219796
Nutr J. 2020 Aug 20;19(1):86
pubmed: 32819372
Eur J Nutr. 2020 Apr;59(3):1093-1103
pubmed: 31055621
Nutr Res. 2021 Nov;95:19-34
pubmed: 34798466
Curr Nutr Rep. 2021 Sep;10(3):179-187
pubmed: 33929703
Am J Clin Nutr. 2022 Jun 7;115(6):1589-1601
pubmed: 35199827
Curr Nutr Rep. 2022 Mar;11(1):39-55
pubmed: 35080755
Front Nutr. 2022 May 13;9:821657
pubmed: 35634416
Global Health. 2021 Jan 26;17(1):17
pubmed: 33499883
Cad Saude Publica. 2010 Nov;26(11):2039-49
pubmed: 21180977
Obes Rev. 2021 Mar;22(3):e13146
pubmed: 33167080
PLoS Med. 2012;9(7):e1001252
pubmed: 22802732
Public Health Nutr. 2019 Apr;22(5):936-941
pubmed: 30744710
Lancet Planet Health. 2021 Aug;5(8):e526-e533
pubmed: 34390670
Obes Rev. 2020 Dec;21(12):e13126
pubmed: 32761763
Obes Rev. 2013 Nov;14 Suppl 2:21-8
pubmed: 24102801
Global Health. 2023 Jan 11;19(1):3
pubmed: 36631805
Int J Behav Nutr Phys Act. 2021 Jun 10;18(1):76
pubmed: 34112183
Int J Health Policy Manag. 2021 Dec 01;10(12):845-856
pubmed: 34634883
Int J Health Policy Manag. 2021 Dec 01;10(12):968-982
pubmed: 34124866
Am J Public Health. 2022 Jun;112(6):853-858
pubmed: 35446606
Global Health. 2022 Jul 23;18(1):72
pubmed: 35870937
Lancet Planet Health. 2020 Oct;4(10):e437-e438
pubmed: 33038314
Nat Food. 2022 Sep;3(9):671-673
pubmed: 37118150

Auteurs

Benjamin Wood (B)

Global Centre for Preventive Health and Nutrition, Institute for Health Transformation, Deakin University, Geelong, Australia. b.wood@deakin.edu.au.

Ella Robinson (E)

Global Centre for Preventive Health and Nutrition, Institute for Health Transformation, Deakin University, Geelong, Australia.

Phillip Baker (P)

Institute for Physical Activity and Nutrition, Deakin University, Geelong, Australia.

Guillermo Paraje (G)

Business School, Universidad Adolfo Ibañez, Santiago de Chile, Chile.

Mélissa Mialon (M)

Trinity Business School, Trinity College, Dublin, Ireland.

Christoffer van Tulleken (C)

University College London, London, UK.

Gary Sacks (G)

Global Centre for Preventive Health and Nutrition, Institute for Health Transformation, Deakin University, Geelong, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH